|
1
|
Allen RA and Lisa JR: Combined liver cell
and bile duct carcinoma. Am J Pathol. 25:647–655. 1949.PubMed/NCBI
|
|
2
|
Jarnagin WR, Weber S, Tickoo SK, Koea JB,
Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH and Klimstra D:
Combined hepatocellular and cholangiocarcinoma: Demographic,
clinical, and prognostic factors. Cancer. 94:2040–2046. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Panjala C, Senecal DL, Bridges MD, Kim GP,
Nakhleh RE, Nguyen JH and Harnois DM: The diagnostic conundrum and
liver transplantation outcome for combined
hepatocellular-cholangiocarcinoma. Am J Transplant. 10:1263–1267.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO classification of tumours of the digestive system.
4th. International Agency for Research on Cancer Publisher, Lyon.
World Health Organization; 2010
|
|
5
|
Kim SH, Park YN, Lim JH, Choi GH, Choi JS
and Kim KS: Characteristics of combined
hepatocelluar-cholangiocarcinoma and comparison with intrahepatic
cholangiocarcinoma. Eur J Surg Oncol. 40:976–981. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chu KJ, Lu CD, Dong H, Fu XH, Zhang HW and
Yao XP: Hepatitis B virus-related combined
hepatocellular-cholangiocarcinoma: Clinicopathological and
prognostic analysis of 390 cases. Eur J Gastroenterol Hepatol.
26:192–199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng W, Yao M, Sai W, Qian Q, Pan L, Qiu
L, Huang J, Wu W and Yao D: Diagnostic and prognostic significance
of secretory clusterin expression in patients with hepatocellular
carcinoma. Tumour Biol. 37:999–1008. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kassahun WT and Hauss J: Management of
combined hepatocellular and cholangiocarcinoma. Int J Clin Pract.
62:1271–1278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zahorec R: Ratio of neutrophil to
lymphocyte counts-rapid and simple parameter of systemic
inflammation and stress in critically ill. Bratisl Lek Listy.
102:5–14. 2001.(In English, Slovak). PubMed/NCBI
|
|
11
|
Sarraf KM, Belcher E, Raevsky E, Nicholson
AG, Goldstraw P and Lim E: Neutrophil/lymphocyte ratio and its
association with survival after complete resection in non-small
cell lung cancer. J Thorac Cardiovasc Surg. 137:425–428. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamanaka T, Matsumoto S, Teramukai S,
Ishiwata R, Nagai Y and Fukushima M: The baseline ratio of
neutrophils to lymphocytes is associated with patient prognosis in
advanced gastric cancer. Oncology. 73:215–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim
YT and Lee K: Pre-treatment neutrophil to lymphocyte ratio is
elevated in epithelial ovarian cancer and predicts survival after
treatment. Cancer Immunol Immunother. 58:15–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
An X, Ding PR, Li YH, Wang FH, Shi YX,
Wang ZQ, He YJ, Xu RH and Jiang WQ: Elevated neutrophil to
lymphocyte ratio predicts survival in advanced pancreatic cancer.
Biomarkers. 15:516–522. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gomez D, Farid S, Malik HZ, Young AL,
Toogood GJ, Lodge JP and Prasad KR: Preoperative
neutrophil-to-lymphocyte ratio as a prognostic predictor after
curative resection for hepatocellular carcinoma. World J Surg.
32:1757–1762. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kayadibi H, Sertoglu E, Uyanik M and Tapan
S: Neutrophil-lymphocyte ratio is useful for the prognosis of
patients with hepatocellular carcinoma. World J Gastroenterol.
20:9631–9632. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oh BS, Jang JW, Kwon JH, You CR, Chung KW,
Kay CS, Jung HS and Lee S: Prognostic value of C-reactive protein
and neutrophil-to-lymphocyte ratio in patients with hepatocellular
carcinoma. BMC Cancer. 13:782013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao WK, Chen D, Li SQ, Fu SJ, Peng BG and
Liang LJ: Prognostic significance of neutrophil-lymphocyte ratio in
hepatocellular carcinoma: A meta-analysis. BMC Cancer. 14:1172014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen SL, Fu SJ, Huang XQ, Chen B, Kuang M,
Li SQ, Hua YP, Liang LJ and Peng BG: Elevated preoperative
peripheral blood monocyte count predicts poor prognosis for
hepatocellular carcinoma after curative resection. BMC Cancer.
14:7442014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Q, Yang LX, Li XD, Yin D, Shi SM,
Chen EB, Yu L, Zhou ZJ, Zhou SL, Shi YH, et al: The elevated
preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis
in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.
Tumour Biol. 36:5283–5289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edge S, Byrd D, Compton C, Fritz A, Greene
F and Trotti A: AJCC cancer staging manual. 7. American Joint
Committee on Cancer; 2010
|
|
22
|
Heagerty PJ, Lumley T and Pepe MS:
Time-dependent ROC curves for censored survival data and a
diagnostic marker. Biometrics. 56:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jaiswal M, LaRusso NF, Burgart LJ and
Gores GJ: Inflammatory cytokines induce DNA damage and inhibit DNA
repair in cholangiocarcinoma cells by a nitric oxide-dependent
mechanism. Cancer Res. 60:184–190. 2000.PubMed/NCBI
|
|
24
|
de Visser KE, Eichten A and Coussens LM:
Paradoxical roles of the immune system during cancer development.
Nat Rev Cancer. 6:24–37. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jackson JR, Seed MP, Kircher CH,
Willoughby DA and Winkler JD: The codependence of angiogenesis and
chronic inflammation. FASEB J. 11:457–465. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ishigami S, Natsugoe S, Tokuda K, Nakajo
A, Che X, Iwashige H, Aridome K, Hokita S and Aikou T: Prognostic
value of intratumoral natural killer cells in gastric carcinoma.
Cancer. 88:577–583. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu CH, Chang SH, Narko K, Trifan OC, Wu
MT, Smith E, Haudenschild C, Lane TF and Hla T: Overexpression of
cyclooxygenase-2 is sufficient to induce tumorigenesis in
transgenic mice. J Biol Chem. 276:18563–18569. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schoppmann SF, Birner P, Stöckl J, Kalt R,
Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K and Kerjaschki
D: Tumor-associated macrophages express lymphatic endothelial
growth factors and are related to peritumoral lymphangiogenesis. Am
J Pathol. 161:947–956. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dannenberg AJ and Subbaramaiah K:
Targeting cyclooxygenase-2 in human neoplasia: Rationale and
promise. Cancer Cell. 4:431–436. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zou W: Immunosuppressive networks in the
tumour environment and their therapeutic relevance. Nat Rev Cancer.
5:263–274. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perez DR, Baser RE, Cavnar MJ,
Balachandran VP, Antonescu CR, Tap WD, Strong VE, Brennan MF, Coit
DG, Singer S and Dematteo RP: Blood neutrophil-to-lymphocyte ratio
is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol.
20:593–599. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Williams KA, Labidi-Galy SI, Terry KL,
Vitonis AF, Welch WR, Goodman A and Cramer DW: Prognostic
significance and predictors of the neutrophil-to-lymphocyte ratio
in ovarian cancer. Gynecol Oncol. 132:542–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cai X, Zhai J, Kaplan DE, Zhang Y, Zhou L,
Chen X, Qian G, Zhao Q, Li Y, Gao L, et al: Background progenitor
activation is associated with recurrence after hepatectomy of
combined hepatocellular-cholangiocarcinoma. Hepatology.
56:1804–1816. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zeng X and Tao H: Diagnostic and
prognostic serum marker of cholangiocarcinoma (Review). Oncol Lett.
9:3–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
